<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="and S-3-hydroxy-4,5-diphenylfuran-2(5H)-one 271 (Figure 9) [88]. An endophytic fungus Pestalotiopsis" exact="microspora" post="isolated from the fruits of Manilkara zapota was cultured"/>
 <result pre="baumannii (ATCCBAA1605). It showed very weak inhibitory effect against M." exact="tuberculosis" post="(MIC &amp;gt; 50 ÂµM) [12]. Compounds 15â€&quot;16 were also"/>
 <result pre="antimicrobial activities against Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa, Klebsiella" exact="pneumonia" post="and Escherichia coli. Compounds 371â€&quot;372 exhibited significant inhibitory activities"/>
 <result pre="were evaluated for their in vitro cytotoxicity against HL60 (human" exact="leukemia" post="60) and HeLa cell lines by the MTT method"/>
 <result pre="activities against three human tumor cell lines HeLa, HCT116 (Human" exact="colon cancer" post="tumor cells), and A549 (Human lung cancer cells), both"/>
 <result pre="against three human tumor cell lines HeLa, HCT116 (Human colon" exact="cancer" post="tumor cells), and A549 (Human lung cancer cells), both"/>
 <result pre="HeLa, HCT116 (Human colon cancer tumor cells), and A549 (Human" exact="lung cancer" post="cells), both of them exhibited weak to moderate cytotoxic"/>
 <result pre="HCT116 (Human colon cancer tumor cells), and A549 (Human lung" exact="cancer" post="cells), both of them exhibited weak to moderate cytotoxic"/>
 <result pre="The in vitro cytotoxicity of compound 119 against the human" exact="acute monocytic leukemia" post="cell line (THP-1) was evaluated using a resazurin-based assay"/>
 <result pre="in vitro cytotoxicity of compound 119 against the human acute" exact="monocytic leukemia" post="cell line (THP-1) was evaluated using a resazurin-based assay"/>
 <result pre="vitro cytotoxicity of compound 119 against the human acute monocytic" exact="leukemia" post="cell line (THP-1) was evaluated using a resazurin-based assay"/>
 <result pre="ATPlite assay. Compound 119 demonstrated marked cytotoxicity against the human" exact="acute monocytic leukemia" post="cell line (THP-1) with the IC50 value of 8.0"/>
 <result pre="assay. Compound 119 demonstrated marked cytotoxicity against the human acute" exact="monocytic leukemia" post="cell line (THP-1) with the IC50 value of 8.0"/>
 <result pre="Compound 119 demonstrated marked cytotoxicity against the human acute monocytic" exact="leukemia" post="cell line (THP-1) with the IC50 value of 8.0"/>
 <result pre="[42]. The in vitro cytotoxicity assay was performed with some" exact="cancer" post="cells including the mouse fibroblast cell line L929, cervix"/>
 <result pre="cervix carcinoma cell line KB-3-1, human breast adenocarcinoma MCF-7, human" exact="prostate cancer" post="PC-3, squamous carcinoma A431, human lung carcinoma A549 and"/>
 <result pre="carcinoma cell line KB-3-1, human breast adenocarcinoma MCF-7, human prostate" exact="cancer" post="PC-3, squamous carcinoma A431, human lung carcinoma A549 and"/>
 <result pre="adenocarcinoma MCF-7, human prostate cancer PC-3, squamous carcinoma A431, human" exact="lung carcinoma" post="A549 and ovarian carcinoma SKOV-3. Compounds 169, 170 showed"/>
 <result pre="Besides, compound 170 showed cytotoxicity against squamous carcinoma A431, human" exact="lung carcinoma" post="A549 and ovarian carcinoma SKOV-3 with IC50 values of"/>
 <result pre="B was used as positive control (IC50 values against 7" exact="cancer" post="cells mentioned above were 0. 8 ng/mL, 0. 06"/>
 <result pre="compounds 190â€&quot;194 were evaluated for their cytotoxic activities against various" exact="cancer" post="cell lines, which include A549, Raji, HepG2, MCF-7, HL-60"/>
 <result pre="221 was assessed for its antiproliferative activities against the mouse" exact="lymphoma" post="(L5178Y) cell line using the in vitro cytotoxicity (MTT)"/>
 <result pre="by the MTT method using a panel of four human" exact="cancer" post="cell lines: NCI-H460 (non-small cell lung cancer), SF-268 (CNS"/>
 <result pre="Compounds 222 and 223 showed moderate cytotoxicity against four human" exact="cancer" post="cell lines with IC50 values of 18.63 Â± 1.82,"/>
 <result pre="control in this assay (IC50 values against the 4 human" exact="cancer" post="cell lines: 0.43 Â± 0.12 ÂµM, 0.61 Â± 0.09"/>
 <result pre="Compound 241 was also tested for cytotoxicity against SH-SY5Y (human" exact="glioma" post="cell lines), HeLa (cervical epithelial cells), HCT116 (human colon"/>
 <result pre="(human glioma cell lines), HeLa (cervical epithelial cells), HCT116 (human" exact="colon cancer" post="cells), HepG2 (human hepatocellular carcinoma cells), A549 (human lung"/>
 <result pre="glioma cell lines), HeLa (cervical epithelial cells), HCT116 (human colon" exact="cancer" post="cells), HepG2 (human hepatocellular carcinoma cells), A549 (human lung"/>
 <result pre="(cervical epithelial cells), HCT116 (human colon cancer cells), HepG2 (human" exact="hepatocellular carcinoma" post="cells), A549 (human lung cancer cells), and MCF7 (human"/>
 <result pre="colon cancer cells), HepG2 (human hepatocellular carcinoma cells), A549 (human" exact="lung cancer" post="cells), and MCF7 (human breast cancer cells). Compound 241"/>
 <result pre="cancer cells), HepG2 (human hepatocellular carcinoma cells), A549 (human lung" exact="cancer" post="cells), and MCF7 (human breast cancer cells). Compound 241"/>
 <result pre="carcinoma cells), A549 (human lung cancer cells), and MCF7 (human" exact="breast cancer" post="cells). Compound 241 showed weak cytotoxic effects against HeLa"/>
 <result pre="cells), A549 (human lung cancer cells), and MCF7 (human breast" exact="cancer" post="cells). Compound 241 showed weak cytotoxic effects against HeLa"/>
 <result pre="Compounds 262,426â€&quot;427 were evaluated for their cytotoxicity against a human" exact="leukemia" post="cell line (K562), a colon adenocarcinoma cell line (SW480),"/>
 <result pre="respectively [86]. Compound 281 was evaluated cytotoxic activities against three" exact="cancer" post="cell lines HCT 116, HeLa, and MCF7, and displayed"/>
 <result pre="IC50 = 23.6 nM. 287 exhibited cytotoxicity against human promyelocytic" exact="leukemia" post="HL60 cells with IC50 value of 1.33 ÂµM. The"/>
 <result pre="cytotoxicities of compound 297 were tested by using human promyelocytic" exact="leukemia" post="HL-60, human hepatoma SMMC-7721, non-small cell lung cancer A-549,"/>
 <result pre="using human promyelocytic leukemia HL-60, human hepatoma SMMC-7721, non-small cell" exact="lung cancer" post="A-549, breast cancer MCF-7 and human colorectal carcinoma SW4801"/>
 <result pre="human promyelocytic leukemia HL-60, human hepatoma SMMC-7721, non-small cell lung" exact="cancer" post="A-549, breast cancer MCF-7 and human colorectal carcinoma SW4801"/>
 <result pre="leukemia HL-60, human hepatoma SMMC-7721, non-small cell lung cancer A-549," exact="breast cancer" post="MCF-7 and human colorectal carcinoma SW4801 cell lines, 297"/>
 <result pre="HL-60, human hepatoma SMMC-7721, non-small cell lung cancer A-549, breast" exact="cancer" post="MCF-7 and human colorectal carcinoma SW4801 cell lines, 297"/>
 <result pre="320 was evaluated for its cytotoxic activities against A549 human" exact="lung cancer" post="cells and HepG2 human liver cancer cells. Compound 320"/>
 <result pre="was evaluated for its cytotoxic activities against A549 human lung" exact="cancer" post="cells and HepG2 human liver cancer cells. Compound 320"/>
 <result pre="activities against A549 human lung cancer cells and HepG2 human" exact="liver cancer" post="cells. Compound 320 exhibited potent cytotoxic activities towards A549"/>
 <result pre="against A549 human lung cancer cells and HepG2 human liver" exact="cancer" post="cells. Compound 320 exhibited potent cytotoxic activities towards A549"/>
 <result pre="cells. Compound 320 exhibited potent cytotoxic activities towards A549 human" exact="lung cancer" post="cells and HepG2 human liver cancer cells with IC50"/>
 <result pre="Compound 320 exhibited potent cytotoxic activities towards A549 human lung" exact="cancer" post="cells and HepG2 human liver cancer cells with IC50"/>
 <result pre="activities towards A549 human lung cancer cells and HepG2 human" exact="liver cancer" post="cells with IC50 values of 23.73 Â± 3.61 ÂµM"/>
 <result pre="towards A549 human lung cancer cells and HepG2 human liver" exact="cancer" post="cells with IC50 values of 23.73 Â± 3.61 ÂµM"/>
 <result pre="findings suggest that compound 337 might be promising lead for" exact="leukemia" post="and lung cancer treatments. In addition, 336 also displayed"/>
 <result pre="that compound 337 might be promising lead for leukemia and" exact="lung cancer" post="treatments. In addition, 336 also displayed anti-tumor activity against"/>
 <result pre="compound 337 might be promising lead for leukemia and lung" exact="cancer" post="treatments. In addition, 336 also displayed anti-tumor activity against"/>
 <result pre="cytotoxicities against three human tumor cell lines, including a human" exact="breast cancer" post="cell line (MDA-MB-435), a human gastric cancer cell line"/>
 <result pre="against three human tumor cell lines, including a human breast" exact="cancer" post="cell line (MDA-MB-435), a human gastric cancer cell line"/>
 <result pre="a human breast cancer cell line (MDA-MB-435), a human gastric" exact="cancer" post="cell line (SGC-7901), and a human lung adenocarcinoma epithelial"/>
 <result pre="The cytotoxicity was evaluated by the [3H] thymidine assay using" exact="breast cancer" post="(MCF-7) and colon cancer (COLO-205) cell lines. Doxorubicin (10"/>
 <result pre="cytotoxicity was evaluated by the [3H] thymidine assay using breast" exact="cancer" post="(MCF-7) and colon cancer (COLO-205) cell lines. Doxorubicin (10"/>
 <result pre="by the [3H] thymidine assay using breast cancer (MCF-7) and" exact="colon cancer" post="(COLO-205) cell lines. Doxorubicin (10 Âµg), was used as"/>
 <result pre="the [3H] thymidine assay using breast cancer (MCF-7) and colon" exact="cancer" post="(COLO-205) cell lines. Doxorubicin (10 Âµg), was used as"/>
 <result pre="[116]. Compound 363 was evaluated for its cytototoxicity against different" exact="cancer" post="cell lines MOLT-4, A549, MDA-MB-231and MIA PaCa-2 by MTT"/>
 <result pre="compound 363 showed considerable cytotoxic potential against the human leukaemia" exact="cancer" post="cell line (MOLT-4) with IC50 value of 20 Âµmol/L,"/>
 <result pre="future developing of antitumor and antimicrobial agents [125]. In the" exact="cancer" post="cell line cytoxicity assays, compound 395 displayed low activity"/>
 <result pre="96-well microplates. Five human tumor cell lines were used: human" exact="myeloid leukemia" post="HL-60, human hepatocellular carcinoma SMMC-7721, lung cancer A-549, breast"/>
 <result pre="microplates. Five human tumor cell lines were used: human myeloid" exact="leukemia" post="HL-60, human hepatocellular carcinoma SMMC-7721, lung cancer A-549, breast"/>
 <result pre="tumor cell lines were used: human myeloid leukemia HL-60, human" exact="hepatocellular carcinoma" post="SMMC-7721, lung cancer A-549, breast cancer MCF-7, and human"/>
 <result pre="were used: human myeloid leukemia HL-60, human hepatocellular carcinoma SMMC-7721," exact="lung cancer" post="A-549, breast cancer MCF-7, and human colon cancer SW480,"/>
 <result pre="used: human myeloid leukemia HL-60, human hepatocellular carcinoma SMMC-7721, lung" exact="cancer" post="A-549, breast cancer MCF-7, and human colon cancer SW480,"/>
 <result pre="myeloid leukemia HL-60, human hepatocellular carcinoma SMMC-7721, lung cancer A-549," exact="breast cancer" post="MCF-7, and human colon cancer SW480, which were obtained"/>
 <result pre="leukemia HL-60, human hepatocellular carcinoma SMMC-7721, lung cancer A-549, breast" exact="cancer" post="MCF-7, and human colon cancer SW480, which were obtained"/>
 <result pre="carcinoma SMMC-7721, lung cancer A-549, breast cancer MCF-7, and human" exact="colon cancer" post="SW480, which were obtained from ATCC (Manassas, VA, USA)."/>
 <result pre="SMMC-7721, lung cancer A-549, breast cancer MCF-7, and human colon" exact="cancer" post="SW480, which were obtained from ATCC (Manassas, VA, USA)."/>
 <result pre="USA). Cisplatin was used as the positive control for the" exact="cancer" post="cell lines (IC50 values against HL-60, A-549, SMMC-7721, MCF-7,"/>
 <result pre="compounds (82â€&quot;92) were tested for their inhibitory activity of Mycobacterium" exact="tuberculosis" post="protein tyrosine phosphatase B (MptpB). Compound 89 displayed inhibition"/>
 <result pre="has been considered as an attractive therapeutic target for the" exact="cancer" post="research. Compound 288 was investigated for its effects on"/>
 <result pre="pancreatic lipase, the 5-lipoxygenase (5-LOX), the Indoleamine 2,3-dioxygenase (IDO), Mycobacterium" exact="tuberculosis" post="protein tyrosine phosphatase B (MptpB), the xanthine oxidase (XO)"/>
 <result pre="in RAW 264.7 macrophage cells (89â€&quot;91)Show comparable inhibition of Mycobacterium" exact="tuberculosis" post="protein tyrosine phosphatase B(89) [38] 83 C25H35NO3 9 84"/>
 <result pre="11 colorless crystal 272 C22H26O6 10 luminous yellow oil Pestalotiopsis" exact="microspora" post="fruits of Manilkara zapota Kandy, Sri Lanka [89] Anthraquinones"/>
</results>
